Work

EFFECT OF G-CSF ON ANC LEVEL IN ALL (Acute Lymphoblastic Leukemia) PATIENT WITH NEUTROPENIA AND FEBRILE NEUTROPENIA DURING CHEMOTHERAPY

Year: 2014
Type: article
Study design: Observational Study
Abstract: Acute Lymphoblastic Leukemia (ALL) is the most common malignancy in children. Chemotherapy-induced neutropenia (CIN) is oneof the serious adverse events that may cause complication such as febrile neutropenia. Neutrophils level is increased using G-CSF,whose effectiveness based on ANC (absolute neutrophil counts) pre and post G-CSF therapy level remains unknown. This study wasto analyze the ANC level changes pre and post G-CSF therapy in neutropenia and febrile neutropenia patients with standard risk andhigh risk chemotherapy protocol. This was a retrospective-observational study from January 2010 to December 2013. Pre-therapyANC level had been collected before receiving G-CSF therapy. Post-therapy ANC level was collected between day 1 to 7 aftertherapy discontinuation. Data were analyzed using paired t-test to determine ANC level changes pre- and post-therapy. Range of GCSFdose of neutropenia vs febrile neutropenia patient with SR protocols therapy was 9.172 ± 1.5646 vs 9.079 ± 1.646 μg/kgBW,and for HR protocols 9.909 ± 1.1229 vs 9.114 ± 1.8551 μg/kgBW/day. In conclusion, G-CSF in a dose of 5-10 μg/kgBW per dayincreases ANC level significantly in ALL patients with neutropenia under high risk and standard risk protocol and in ALL patientswith febrile neutropenia under standard risk protocol. However, the increase of ANC level is not significant in ALL patients withfebrile neutropenia under high risk protocol. (FMI 2014;50 179-186)
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
Estimated APC paid: $98
OpenAlex ID: W2221316430
FWCI:
Cites: 2
Cited by:
Related to: 10